CD19-directed autologous CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19-directed autologous CAR-T cells, covering 2025-06-17 to 2025-06-17. Get the full timeline:
Most recent: Clinical Trial Update: A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia [Phase 1]